ADSK - AUTOCAD will not cure cancer
May rise a bit into an earnings by end of FEB , however it's been a nice 25% move in stock price without any cool off.
Watching for divergency flip.
Watching for divergency flip.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.